Wassim Labaki is a Respiratory physician affiliated with University of Michigan. OpenAlex indexes 230 publications with 3,562 citations (h-index 31).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Inogen, Inc.Program year202511 payments$11,022openpaymentsdata.cms.gov ↗
- Verona Pharma, Inc.Program year20251 payment
- AstraZeneca UK LimitedProgram year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
64.1%Corticosteroid34.7%Trelegy Ellipta43%Breztri Aerosphere26%Breo Ellipta11%Fluticasone Propionate11%Budesonide-Formoterol Fumarate10%Part D<11 patientsbeta2-Adrenergic Agonist24.8%Albuterol Sulfate Hfa66%Ventolin Hfa18%Striverdi Respimat16%Part D<11 patients+ 1 more class in this area
Anti-infectives
21.1%Macrolide Antimicrobial21.1%Azithromycin100%Part D≥20 patientsMetabolism & gastrointestinal
14.9%Corticosteroid14.9%Prednisone100%Part D≥27 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2020–2026 per NIH RePORTER. The latest:
- High performance wearable body odor sensor arrays for disease detection and monitoring
University of Michigan at Ann Arbor
FY2026$1,154,765U01TR004066 - High performance wearable body odor sensor arrays for disease detection and monitoring
University of Michigan at Ann Arbor
FY2025$1,192,517U01TR004066 - Leveraging Serum Metabolomics to Understand Clinical Phenotypes in COPD
University of Michigan at Ann Arbor
FY2024$174,960K23HL151751
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Chronic Obstructive Pulmonary Disease Exacerbations Increase the Risk of Subsequent Cardiovascular Events: A Longitudinal Analysis of the COPDGene Study
Journal of the American Heart Association
2024 - Causes of and Clinical Features Associated with Death in Tobacco Cigarette Users by Lung Function Impairment
American Journal of Respiratory and Critical Care Medicine
2023 - Blood Gene Expression and Immune Cell Subtypes Associated with Chronic Obstructive Pulmonary Disease Exacerbations
American Journal of Respiratory and Critical Care Medicine
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Max Wicha, MD
University of Michigan
Dinesh Khanna, MD
University of Michigan
Eva Feldman, MD
University of Michigan
Matthias Kretzler, MD
University of Michigan
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”